Navigation Links
Demographic Change Demand a New Life-Course for Aging Society

21st century will be a century of redistribution of work’, says James W. Vaupel.

In theory, there are a number of ways to spread the total number of hours worked more evenly over the ages of life. One option would be to increase work participation of people in their 50s, using intelligent concepts of part-time work. Currently, their participation is declining markedly compared to the under-50s. Against the background of people living longer and tending to live healthier, even the over-60s could be integrated into working life to some degree. An even and flexible distribution of work could also reduce the burden placed on people aged 35 to 50. Their work phase, intense as it is, clashes with the time they need to establish a family and rear children. If work was distributed more evenly over the ages of life, then individuals could do more in life: They could combine education, work, leisure, family, and social engagement in varying amounts and according to the requirements of each life phase. Today, however, there are large obstacles to the coexistence of these spheres of life.

In the face of demographic change, the re-distribution of work over the life-course has become an economic necessity. Social science can continue to make a valuable contribution to fathom out the conditions of and obstacles to shaping new life-courses.

Source: Eurekalert
'"/>




Page: 1 2

Related medicine news :

1. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
2. Change in walking might indicate Dementia
3. Change in weight not a risk in healthy men
4. Changes in cabin pressure pose risks for moms-to-be
5. Dietary Changes Could Reduce The Risk for Stroke
6. Link Between High Blood Sugar And Behavioral Changes
7. Improving Lighting Could Bring About A Change In Alzheimers Patients
8. Specific Changes In A Particular Gene Found To Increase The Risk of Alzheimer’s Diseas
9. Impotence Drugs Ordered by FDA to have Label Change
10. Ultrasounds To Detect Changes In Heart Motions
11. Change In Diet May Slow The Progression Of Prostate Cancer

Post Your Comments:
(Date:11/23/2009)...ease the problem, researchers say , , MO...p their anger over unfair treatment at work could ...ates. , Men who consistently failed to express ...er or supervisor were more than twice as likely to...ose who vented their anger, claims a report in the...
(Date:11/23/2009)...alsintheRecommendedPriorityGroups ,, HARRISBURG...tofHealthannouncedtodaytheywillconductthreeadditio...inDelaware,Lancaster,andLehighcountiesonTuesday,No...isteredforfreetoindividualsintherecommendedtargetg...epartmentasksthatonlyindividualsinthefollowinggrou...
(Date:11/23/2009)... survivors treated with chemotherapy suffer insomn...nditions, hindering patients, ability to fully rec... Rochester Medical Center. , A study of 823 canc... at nearly three times the rate of the general pop... patients and those with lung and breast cancers, ...
(Date:11/23/2009)...f-its-kind consensus statement on diabetes surgery...ry . The report illustrates the findings of the fi... Surgery Summit (DSS) -- where an international gr... agreed on a set of evidence-based guidelines and ...udy of gastrointestinal surgery to treat type 2 di...
(Date:11/23/2009)... who reined in their hypertension, study found, ,...igh blood pressure is better controlled by doctor-...ors and pharmacists working alone, a new study sho...edications are intensified, dosages increased, med...ter, a professor in the University of Iowa College...
Breaking Medicine News(10 mins):Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 3Health News:Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties 2Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 4Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 5Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 2Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 3
...bs to Lodi , , LODI, Calif., Dec. 4 Moving f...ommunity, Blue Shield of California celebrates the...ervice center today with a ribbon-cutting ceremony...es working in customer service, claims and members...
... of the findings of its 5th,International Nutritio...,nutrition and its importance in elite physical pe...ram on the specific nutritional needs of athletes,...ich,should lead to a new generation of personalize...
...ma who are exposed to environmental tobacco smoke ...depression and other behavioral problems, accordin... Medical Center. , In a study posted online ahead...vels, but they added even low levels of tobacco sm...
...rs, LLC, a specialty,bank consulting firm, has mov...rk (JHFN). Through Empire Financial Partners, an i...k in Buffalo, NY, they will offer bank owned life,...o offer this specialized knowledge and,experience ...
...ch as in the skin, intestinal mucosa or blood, hav... to function, a steady replenishment of specialize...alled "adult" stem cells also known as tissue stem...ective tissue a property called pluripotency. Se...
...giCount Medical,Inc., a division of Patient Safety...day announced that it has joined The Leapfrog Grou... create a safer, higher quality health care,system...o an affiliation with,Leapfrog. We share a common ...
Other Medicine News:Health News:Blue Shield of California Celebrates Completion of New Lodi Campus 2Health News:Blue Shield of California Celebrates Completion of New Lodi Campus 3Health News:Nestle Launches New Research Program on the Specific Nutritional Needs of Athletes 2Health News:Nestle Launches New Research Program on the Specific Nutritional Needs of Athletes 3Health News:Study strengthens link between tobacco smoke and behavioral problems in boys with asthma 2Health News:Study strengthens link between tobacco smoke and behavioral problems in boys with asthma 3Health News:John Hancock Financial Network Offers Bank Owned Life Insurance Resource to Its Independent Career Firms Nationally 2Health News:John Hancock Financial Network Offers Bank Owned Life Insurance Resource to Its Independent Career Firms Nationally 3Health News:Dormant stem cells for emergencies 2Health News:Dormant stem cells for emergencies 3Health News:SurgiCount Medical Joins The Leapfrog Group 2
(Date:11/23/2009)....23/PRNewswire/--LigonDiscovery,Inc.,whichusesprop...sagainsthigh-valuetargets,todayannouncedtheappoint...sLigon,sExecutiveChairmanoftheBoard. ,, "I,mver...theBoard,"saidPatrickKleyn,Ligon,schiefexecutiveof...enceinthelifesciencesindustry--particularlyhislead...
(Date:11/23/2009)...ovalsoftwonewtherapiesforNon-Hodgkin,sLymphomas(NH...ofatumumab(Azerra(TM),GlaxoSmithKline)asatherapyop...andromidepsin(Istodax(R),GloucesterPharmaceuticals...lllymphoma(CTCL). ,, FORTWASHINGTON,Pa.,Nov.23/...romptedtheNationalComprehensiveCancerNetwork( NCCN...
(Date:11/23/2009)...wswire/--Reportlinker.comannouncesthatanewmarketre...calNonwovenDisposables-AWorldwideMarketReview ,...Nonwoven-Disposables---A-Worldwide-Market-Review.h...m_campaign=prnewswire ,, Withincreaseinrang...healthcareandhospitalfacilities,nonwovenshasemerge...
Breaking Medicine Technology:Ligon Discovery Announces Appointment of Errol B. De Souza as Executive Chairman 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 3Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 2Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 3Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 4Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 5Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 6Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 7Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 8Arcadian Health Names Rick Click as New Chief Information Officer 58491 1Arcadian Health Names Rick Click as New Chief Information Officer 58491 2Cadence Pharmaceuticals CEO Ted Schroeder to Present at the JMP Securities Healthcare Focus Conference in New York on October 6 2009 58489 1Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cance 58487 1Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cance 58487 2Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cance 58487 3Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cance 58487 4Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cance 58487 5Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cance 58487 6
...x to Fund Human Clinical Trials, MINNEAPOLIS, Oct... $20 million Series B financing. Co-Founded in Jul...utonix is a medical device company,focused on the ...alloon,angioplasty technology for the treatment an...nosis caused by atherosclerosis. Lutonix,s drug co...
...es for the most common, pathogens, including meth...EINACH, Switzerland, Oct. 26 Arpida (SWX:,ARPN) t...al Phase III,clinical trials at the 48th Interscie...erapy (ICAAC)/Infectious Diseases Society of Ameri...n these studies, intravenous iclaprim, a,novel ant...
Other Medicine Technology:Lutonix Inc. Announces $20 Million Series B Financing 2Lutonix Inc. Announces $20 Million Series B Financing 3Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 2Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 3Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 4Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 5Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 6Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 7
Replacement Bulb: HBO 50W/3
Replacement Bulb: FCS
Replacement Bulb: ELC 64653HLX
Replacement Bulb: EFR
Medicine Products: